BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7154937)

  • 21. Folinic acid attenuates methotrexate chemotherapy-induced damages on bone growth mechanisms and pools of bone marrow stromal cells.
    Xian CJ; Cool JC; Scherer MA; Fan C; Foster BK
    J Cell Physiol; 2008 Mar; 214(3):777-85. PubMed ID: 17786974
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased bone formation by intermittent parathyroid hormone administration is due to the stimulation of proliferation and differentiation of osteoprogenitor cells in bone marrow.
    Nishida S; Yamaguchi A; Tanizawa T; Endo N; Mashiba T; Uchiyama Y; Suda T; Yoshiki S; Takahashi HE
    Bone; 1994; 15(6):717-23. PubMed ID: 7873302
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The preosteoclast and its cytodifferentiation into the osteoclast: ultrastructural and histochemical studies of rat fetal parietal bone.
    Ejiri S
    Arch Histol Jpn; 1983 Sep; 46(4):533-57. PubMed ID: 6661003
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro and in vivo effects of indomethacin on phytohemagglutinin-stimulated lymphocyte mitogenesis.
    Seng GF; Gay BJ; Bayer BM
    Biochem Pharmacol; 1987 Feb; 36(4):507-11. PubMed ID: 3827938
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased bone growth by local prostaglandin E2 in rats.
    Yang RS; Liu TK; Lin-Shiau SY
    Calcif Tissue Int; 1993 Jan; 52(1):57-61. PubMed ID: 8453506
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The cross-talk between osteoclasts and osteoblasts in response to strontium treatment: involvement of osteoprotegerin.
    Peng S; Liu XS; Huang S; Li Z; Pan H; Zhen W; Luk KD; Guo XE; Lu WW
    Bone; 2011 Dec; 49(6):1290-8. PubMed ID: 21925296
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of hind limb unloading and reloading on nitric oxide synthase expression and apoptosis of osteocytes and chondrocytes.
    Basso N; Heersche JN
    Bone; 2006 Oct; 39(4):807-14. PubMed ID: 16765658
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vasoactive intestinal peptide regulates osteoclast activity via specific binding sites on both osteoclasts and osteoblasts.
    Lundberg P; Lie A; Bjurholm A; Lehenkari PP; Horton MA; Lerner UH; Ransjö M
    Bone; 2000 Dec; 27(6):803-10. PubMed ID: 11113391
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chondrocytic ephrin B2 promotes cartilage destruction by osteoclasts in endochondral ossification.
    Tonna S; Poulton IJ; Taykar F; Ho PW; Tonkin B; Crimeen-Irwin B; Tatarczuch L; McGregor NE; Mackie EJ; Martin TJ; Sims NA
    Development; 2016 Feb; 143(4):648-57. PubMed ID: 26755702
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thyroid-stimulating hormone restores bone volume, microarchitecture, and strength in aged ovariectomized rats.
    Sampath TK; Simic P; Sendak R; Draca N; Bowe AE; O'Brien S; Schiavi SC; McPherson JM; Vukicevic S
    J Bone Miner Res; 2007 Jun; 22(6):849-59. PubMed ID: 17352644
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increases in number and size of osteoclasts in response to calcium or phosphorus deficiency in the rat.
    Thompson ER; Baylink DJ; Wergedal JE
    Endocrinology; 1975 Aug; 97(2):283-9. PubMed ID: 1157752
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biomechanically stimulated chondrocytes promote osteoclastic bone resorption in the mandibular condyle.
    Kuang B; Zeng Z; Qin Q
    Arch Oral Biol; 2019 Feb; 98():248-257. PubMed ID: 30530236
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Psoralidin, a prenylated coumestan, as a novel anti-osteoporosis candidate to enhance bone formation of osteoblasts and decrease bone resorption of osteoclasts.
    Zhai Y; Li Y; Wang Y; Cui J; Feng K; Kong X; Chen L
    Eur J Pharmacol; 2017 Apr; 801():62-71. PubMed ID: 28283388
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insulin-like growth factor-I increases trabecular bone formation and osteoblastic cell proliferation in unloaded rats.
    Machwate M; Zerath E; Holy X; Pastoureau P; Marie PJ
    Endocrinology; 1994 Mar; 134(3):1031-8. PubMed ID: 8119139
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Damaging effects of chronic low-dose methotrexate usage on primary bone formation in young rats and potential protective effects of folinic acid supplementary treatment.
    Fan C; Cool JC; Scherer MA; Foster BK; Shandala T; Tapp H; Xian CJ
    Bone; 2009 Jan; 44(1):61-70. PubMed ID: 18976724
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of dichloromethylene diphosphonate, a pyrophosphate analog, on bone and bone cell structure in the growing rat.
    Miller SC; Jee WS
    Anat Rec; 1979 Mar; 193(3):439-62. PubMed ID: 154858
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Short-term local injections of transforming growth factor-beta 1 decrease ovariectomy-stimulated osteoclastic resorption in vivo in rats.
    Beaudreuil J; Mbalaviele G; Cohen-Solal M; Morieux C; De Vernejoul MC; Orcel P
    J Bone Miner Res; 1995 Jun; 10(6):971-7. PubMed ID: 7572322
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bone morphogenetic protein (BMP) localization in developing human and rat growth plate, metaphysis, epiphysis, and articular cartilage.
    Anderson HC; Hodges PT; Aguilera XM; Missana L; Moylan PE
    J Histochem Cytochem; 2000 Nov; 48(11):1493-502. PubMed ID: 11036092
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Histochemical examination of osteoblastic activity in op/op mice with or without injection of recombinant M-CSF.
    Nishino I; Amizuka N; Ozawa H
    J Bone Miner Metab; 2001; 19(5):267-76. PubMed ID: 11498728
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of spaceflight on trabecular bone in rats.
    Jee WS; Wronski TJ; Morey ER; Kimmel DB
    Am J Physiol; 1983 Mar; 244(3):R310-4. PubMed ID: 6829790
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.